Autologous bone marrow transplantation (ABMT) versus sequential chemotherapy for aggressive non Hodgkin's lymphoma (NHL) in first complete remission (CR): A study of 542 patients (LNH87-2 protocol).

被引:0
|
作者
Haioun, C [1 ]
Lepage, E [1 ]
Gisselbrecht, C [1 ]
Coiffier, B [1 ]
Bosly, A [1 ]
Dupriez, B [1 ]
Nouvel, C [1 ]
Tilly, H [1 ]
Lederlin, P [1 ]
Biron, P [1 ]
Briere, J [1 ]
Gaulard, P [1 ]
Reves, F [1 ]
机构
[1] HOP HENRI MONDOR,F-94010 CRETEIL,FRANCE
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1816 / 1816
页数:1
相关论文
共 50 条
  • [21] Autologous bone marrow transplantation in relapses of chemotherapy-sensitive aggressive non-Hodgkin's lymphoma: Long-term outcome
    Lalle, M
    Montuoro, A
    JOURNAL OF CHEMOTHERAPY, 2000, 12 (05) : 431 - 434
  • [22] Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry
    Vose, JM
    Zhang, MJ
    Rowlings, PA
    Lazarus, HM
    Bolwell, BJ
    Freytes, CO
    Pavlovsky, S
    Keating, A
    Yanes, B
    van Besien, K
    Armitage, JO
    Horowitz, MM
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 406 - 413
  • [23] Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study
    Bosly, A
    Lepage, E
    Coiffier, B
    Dupriez, B
    Herbrecht, R
    Fillet, G
    Divine, M
    Nouvel, C
    Tilly, H
    Bordessoule, D
    Gaulard, P
    Gisselbrecht, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 546 - 546
  • [24] Autologous blood or bone marrow transplantation (BBMT) for patients with non-Hodgkin's lymphoma (NHL) involving the central nervous system (CNS).
    Alvarnas, JC
    Long, GD
    Negrin, RS
    Hu, WW
    Horning, SJ
    Tierney, DK
    Blume, KG
    Chao, NJ
    BLOOD, 1995, 86 (10) : 820 - 820
  • [25] A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of autologous stem cell transplantation in first remission on outcome
    Fanin, R
    Sperotto, A
    De Elvira, CR
    Zaja, F
    Stocchi, R
    Geromin, A
    Cerno, M
    Patriarca, F
    Canelles, MF
    Damiani, D
    Baccarani, M
    HAEMATOLOGICA, 2000, 85 (09) : 943 - 951
  • [26] High-dose chemotherapy with autologous stem cell transplantation in poor-risk aggressive non-Hodgkin lymphoma in first complete remission: an analysis of the prospective Tunisian study
    Torjemane, L.
    Ladeb, S.
    Lakhal, A.
    Abdelkefi, A.
    Ben Abdelhadhim, A.
    Ben Othman, T.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S256 - S256
  • [27] Cost analysis of autologous peripheral stem cell transplantation versus autologous bone marrow transplantation for patients with non Hodgkin's lymphoma and acute lymphoblastic leukaemia
    Jerjis, S
    Croockewit, S
    Muus, P
    Schaap, N
    Preijers, F
    De Witte, T
    LEUKEMIA & LYMPHOMA, 1999, 36 (1-2) : 33 - 43
  • [28] Phase III study comparing pixy321 and GM-CSF following autologous bone marrow transplantation (ABMT) in patients with nonHodgkin's lymphoma (NHL)
    Vose, JM
    Pandite, L
    Beveridge, RA
    Geller, RB
    Schuster, MW
    Anderson, JE
    LeMaistre, CF
    Lebsack, ME
    BLOOD, 1995, 86 (10) : 3876 - 3876
  • [29] Outcome according to the international prognostic index of patients with aggressive non Hodgkin's lymphoma submitted to autologous stem cell transplantation in first remission.
    Fanin, R
    Silvestri, F
    Geromin, A
    Cerno, M
    Infanti, L
    Stocchi, R
    Sperotto, A
    Damiani, D
    Baccarani, M
    BLOOD, 1996, 88 (10) : 467 - 467
  • [30] Intensive chemotherapy followed by autologous bone marrow and peripheral blood progenitor cells transplantation improves treatment results in patients with aggressive non-Hodgkin lymphoma
    Melkova, K
    Oboukhova, E
    Gorbounova, N
    Baranov, A
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1371 - 1374